2026 Eva Harris: Immunology Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Immunology	110	507	469	307	279	394	40896
Medicine	110	5601	5262	3012	2792	396	40911

Research.com Recognitions

1999 - Hellman Fellow
1997 - Fellow of the MacArthur Foundation

Overview

Eva Harris is affiliated with the University of California, Berkeley in the United States. Their research primarily spans the field of Medicine with a focus on Public Health, Environmental and Occupational Health, Infectious Diseases, Epidemiology, Modeling and Simulation, and Molecular Biology.

The scientist's work covers several main topics including:

Mosquito-borne diseases and control
Viral Infections and Vectors
Malaria Research and Control
SARS-CoV-2 and COVID-19 Research
COVID-19 epidemiological studies
Viral Infections and Outbreaks Research
Virology and Viral Diseases

Recent publications by Eva Harris include:

"Zika virus infection enhances future risk of severe dengue disease," 2020, Science
"Structural basis for antibody inhibition of flavivirus NS1-triggered endothelial dysfunction," 2021, Science
"Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection," 2022, Nature Genetics
"Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responses," 2022, Nature Immunology
"Pan-vaccine analysis reveals innate immune endotypes predictive of antibody responses to vaccination," 2022, Nature Immunology

Frequent co-authors collaborating with Eva Harris include Ángel Balmaseda, Guillermina Kuan, Aubree Gordon, Scott B. Biering, and José Víctor Zambrana.

The scientist publishes regularly in venues such as bioRxiv (Cold Spring Harbor Laboratory), UNC Libraries, Journal of Virology, PLoS Neglected Tropical Diseases, and Nature Communications.

Eva Harris has also contributed to book publications, including a title published by Cambridge University Press: "Migration" (2020).

Awards received by Eva Harris include the Hellman Fellow award in 1999 and a fellowship from the MacArthur Foundation in 1997.

Best Publications

Dengue

Unknown

1268
Citations
Antibody-dependent enhancement of severe dengue disease in humans

Leah C. Katzelnick;Lionel Gresh;M. Elizabeth Halloran;M. Elizabeth Halloran;Juan Carlos Mercado

1205
Citations
Global burden of respiratory infections due to seasonal influenza in young children: a systematic review and meta-analysis

Harish Nair;Harish Nair;W Abdullah Brooks;Mark Katz;Anna Roca

1203
Citations
Global spread and persistence of dengue.

Jennifer L. Kyle;Eva Harris

1175
Citations
Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection

Karin Stettler;Martina Beltramello;Diego A. Espinosa;Victoria Graham

861
Citations
The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity

Martina Beltramello;Katherine L. Williams;Cameron P. Simmons;Annalisa Macagno

707
Citations
Recent Advances in Deciphering Viral and Host Determinants of Dengue Virus Replication and Pathogenesis

Karen Clyde;Jennifer L. Kyle;Eva Harris

625
Citations
Emergence and Global Spread of a Dengue Serotype 3, Subtype III Virus

William B. Messer;Duane J. Gubler;Eva Harris;Kamalanayani Sivananthan

571
Citations
Dengue virus NS1 triggers endothelial permeability and vascular leak that is prevented by NS1 vaccination

P. Robert Beatty;Henry Puerta-Guardo;Sarah S. Killingbeck;Dustin R. Glasner

563
Citations
The WHO dengue classification and case definitions: time for a reassessment.

Jacqueline L Deen;Eva Harris;Bridget Wills;Angel Balmaseda

552
Citations
Zika Virus Targets Different Primary Human Placental Cells, Suggesting Two Routes for Vertical Transmission.

Takako Tabata;Matthew Petitt;Henry Puerta-Guardo;Daniela Michlmayr

538
Citations
Lethal Antibody Enhancement of Dengue Disease in Mice Is Prevented by Fc Modification

Scott J. Balsitis;Katherine L. Williams;Ruben Lachica;Diana Flores

499
Citations
Differences in dengue severity in infants, children, and adults in a 3-year hospital-based study in Nicaragua.

Samantha Nadia Hammond;Angel Balmaseda;Leonel Pérez;Yolanda Tellez

485
Citations
Modulation of Dengue Virus Infection in Human Cells by Alpha, Beta, and Gamma Interferons

Michael S. Diamond;Michael S. Diamond;T. Guy Roberts;Dianna Edgil;Betty Lu

441
Citations
Dengue subgenomic RNA binds TRIM25 to inhibit interferon expression for epidemiological fitness

Gayathri Manokaran;Esteban Finol;Esteban Finol;Chunling Wang;Jayantha Gunaratne;Jayantha Gunaratne

439
Citations
Murine Model for Dengue Virus-Induced Lethal Disease with Increased Vascular Permeability

Sujan Shresta;Kristin L. Sharar;Daniil M. Prigozhin;P. Robert Beatty

421
Citations
Typing of dengue viruses in clinical specimens and mosquitoes by single-tube multiplex reverse transcriptase PCR

Eva Harris;T. Guy Roberts;Leila Smith;John Selle

416
Citations
Serotype-specific differences in clinical manifestations of dengue.

Angel Balmaseda;Samantha N. Hammond;Leonel Pérez;Yolanda Tellez

413
Citations
Viremia and Clinical Presentation in Nicaraguan Patients Infected With Zika Virus, Chikungunya Virus, and Dengue Virus

Jesse Waggoner;Lionel Gresh;Maria Jose Jose Vargas;Gabriela Ballesteros

410
Citations
Clinical, epidemiologic, and virologic features of dengue in the 1998 epidemic in Nicaragua.

Eva Harris;Elsa Videa;Leonel Perez;Erick Sandoval

402
Citations
Interferon-Dependent Immunity Is Essential for Resistance to Primary Dengue Virus Infection in Mice, Whereas T- and B-Cell-Dependent Immunity Are Less Critical

Sujan Shresta;Jennifer L. Kyle;Heidi M. Snider;Manasa Basavapatna

396
Citations

Frequent Co-Authors

Angel Balmaseda University of California, Berkeley

Neil Andersson McGill University

Aravinda M. de Silva University of North Carolina at Chapel Hill

Alessandro Sette La Jolla Institute For Allergy & Immunology

Daniela Weiskopf La Jolla Institute For Allergy & Immunology

Sergio R. Ojeda Oregon National Primate Research Center

Anna P. Durbin Johns Hopkins University

Benjamin A. Pinsky Stanford University

Cameron P. Simmons University College London

Laura D. Kramer University at Albany, State University of New York

External Links

Wikipedia of Eva Harris Personal website of Eva Harris

If you think any of the details on this page are incorrect, let us know.

Related Online Degrees & Career Pathways

Studying Immunology opens doors to diverse healthcare and research careers, many of which benefit from complementary nursing qualifications. For professionals aiming to enhance their clinical expertise, exploring an fnp to acute care np bridge program can be an effective way to transition into specialized acute care roles. These bridge programs build upon Family Nurse Practitioner experience, aligning well with immunology-focused patient care.

For those new to nursing but interested in a faster route to becoming a nurse practitioner, an accelerated fnp program offers an efficient pathway to enter the field with advanced qualifications. Such programs are designed for speed without compromising on quality, catering to students passionate about immunology and patient wellness.

Non-nurses considering a career shift can explore the best online rn programs for non nurses. These programs provide foundational nursing knowledge essential for clinical roles connected to immunology research or treatment.

Additionally, individuals seeking accessible entry points into nursing may find numerous absn programs with high acceptance rates. These accelerated Bachelor of Science in Nursing degrees offer a practical and attainable way to launch a nursing career, complementing studies in immunology with hands-on healthcare experience.